6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors

Details for Australian Patent Application No. 2004295059 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Wouters, Walter Boudewijn Leopold; Guillemont, Jerome Emile Georges; Somers, Maria Victorina Francisca; Mabire, Dominique Jean-Pierre; Van Dun, Jacobus Alphonsus Josephus

Agent Shelston IP

Pub. Number AU-B-2004295059

PCT Pub. Number WO2005/054210

Priority 03078859.0 05.12.03 EP

Filing date 18 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 16 December 2010

International Classifications

C07D 241/44 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 407/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/054210 Priority application(s): WO2005/054210

16 December 2010 Application Accepted

  Published as AU-B-2004295059

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295060-Phosphinic acid derivatives

2004295058-6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors